For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251110:nRSJ7681Ga&default-theme=true
RNS Number : 7681G Princes Group PLC 10 November 2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, DIRECTLY OR
INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA
OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD BE UNLAWFUL.
10 November 2025
Princes Group plc
Stabilisation Notice
Further to the pre-stabilisation period announcement dated 31 October 2025,
Peel Hunt LLP (the "Stabilising Manager") hereby gives notice that the
Stabilising Manager has undertaken stabilisation within the meaning of Article
3.2(d) of the Regulation (EU) No 596/2014 (Market Abuse Regulation) and the
delegated acts, implementing acts, and technical standards and guidelines
thereunder as such legislation forms part of retained EU law by virtue of the
European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU)
2016/1052 as it forms part of retained EU law by virtue of the European Union
(Withdrawal) Act 2018, in relation to the offer of the following securities.
The Securities:
Issuer: Princes Group plc
Securities Ordinary registered shares of £0.10 nominal value each ("Ordinary Shares") of
the Issuer (ISIN: GB00BVZNY531)
Offering size: 84,210,526 Ordinary Shares (excluding the over-allotment option)
Offer Price 475 pence per Offer Share
Stabilisation:
Stabilising Manager (and central point within the meaning of Commission Peel Hunt LLP
Delegated Regulation 2016/1052 as it forms part of retained EU law by virtue
of the European Union (Withdrawal) Act 2018): 7th Floor, 100 Liverpool Street, London, EC2M 2AT, United Kingdom
Contact: Sohail Akbar; Nicolas Wilks; telephone: +44 (0)20 7418 8900
Trading venue where stabilisation transactions were undertaken: London Stock Exchange
For each of the dates during which stabilisation transactions were carried out
during the period covered by this announcement, the aggregate quantity and
price range was as follows:
Execution date Aggregate Quantity of Ordinary Shares Lowest Price Highest Price Trading Venue
31 October 2025 1,078,282 470.0 475.0 XLOM
03 November 2025 466,733 460.0 470.0 XLOM
04 November 2025 350,178 450.0 455.0 XLOM
05 November 2025 134,000 455.0 465.0 XLON
06 November 2025 168,728 465.0 468.55 XLON
07 November 2025 240,000 441.0 470.0 XLON
Disclaimer
In connection with the offer of the above securities, the Stabilising Manager
or any of its agents may over-allot the securities or effect transactions with
a view to supporting the market price of the securities at a level higher than
that which might otherwise prevail. However, there is no assurance that the
Stabilising Manager or any of its agents will take any stabilisation action
and any stabilisation action, if begun, may be ended at any time. Any
stabilisation action or overallotment shall be conducted in accordance with
all applicable laws and rules.
This announcement is for information only and does not constitute an offer or
invitation to underwrite, subscribe for or otherwise acquire or dispose of any
securities or investment advice in any jurisdiction in which such an offer or
solicitation is unlawful, including without limitation, the United States,
Australia, Canada, or Japan. Any failure to comply with these restrictions may
constitute a violation of the securities laws of such jurisdictions.
This announcement and the information contained herein, is not an offer of
securities for sale in, and is not for transmission to or publication,
distribution or release, directly or indirectly, in the United States of
America (including its territories and possessions, any state of the United
States of America and the District of Columbia) (the "United States"). The
securities being offered have not been and will not be registered under the US
Securities Act of 1933, as amended (the "Securities Act"), or under any
applicable securities laws of any state or other jurisdiction of the United
States and may not be offered, sold, resold, transferred or delivered,
directly or indirectly, in the United States unless registered under the
Securities Act or pursuant to an exemption from, or in a transaction not
subject to, such registration requirements and in accordance with any
applicable securities laws of any state or other jurisdiction of the United
States. No public offering of the securities discussed herein is being made in
the United States.
In the United Kingdom, this announcement is being distributed only to, and is
directed only at, persons who: (A) (i) are "investment professionals"
specified in Article 19(5) of the Financial Services and Markets Act
(Financial Promotion) Order 2005 (the "Order") and/or (ii) fall within Article
49(2)(a) to (d) of the Order (and only where the conditions contained in those
Articles have been, or will at the relevant time be, satisfied); and (B) are
"qualified investors" within the meaning of Article 2 of the Prospectus
Regulation (Regulation (EU) 2017/1129) as it forms part of retained EU law as
defined in the EU (Withdrawal) Act 2018 (all such persons together being
referred to as "Relevant Persons"). In the European Economic Area (the "EEA"),
this announcement is addressed only to and directed only at, persons in member
states who are "qualified investors" within the meaning of Article 2(e) of the
Prospectus Regulation (Regulation ((EU) 2017/1129) ("Qualified Investors").
This announcement must not be acted on or relied on (i) in the United Kingdom,
by persons who are not Relevant Persons, and (ii) in any member state of the
EEA, by persons who are not Qualified Investors. Any investment or investment
activity to which this announcement relates is available only to: (i) in the
United Kingdom, Relevant Persons; and (ii) in any member state of the EEA,
Qualified Investors, and will be engaged in only with such persons.
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END STAMZMGMRRZGKZM
Copyright 2019 Regulatory News Service, all rights reserved